Gador S.A. is a leader argentine pharmaceutical company, founded in 1940, and with more than 50 years experience in the synthesis of Active Pharmaceutical Ingredients.
GADOR S.A. API Division provides a wide range of products for human use such as bone resorption inhibitors, hormones and drugs for treatment of central nervous system disorders (Product List).
Our manufacturing facilities and systems comply with the highest standards of cGMP, guaranteed by an effective quality system, the support of state-of-the-art equipment and facilities, and a highly trained staff.
Through quality excellence in every single step of the process, we meet one of Gador’s goals providing our clients with a distinguished service, in order to remain competitive. This is achieved through special care based on complete and accurate documentation, the necessary technical support, and dynamic response to custumers and authorities. These facts facilitate a fast track regulatory approval.
Gador S.A. API Division has successfully undergone a number of inspections carried out by the Food and Drug Administration from the USA (FDA), the Therapeutic Good Administration from Australia (TGA), The agence Française de sécurité sanitaire des produits de Santé (AFFSAPS), and the MERCOSUR health authorities. The company also hosts audits from clients from Europe, United States of America, Asia and Australia on a regular basis.